Literature DB >> 21975260

Diagnostic accuracy of ¹²³I-FP-CIT (DaTSCAN) in dementia with Lewy bodies: a meta-analysis of published studies.

Nikolaos D Papathanasiou1, Anastasios Boutsiadis, John Dickson, Jamshed B Bomanji.   

Abstract

PURPOSE: A systematic meta-analysis of published studies on the diagnostic accuracy of presynaptic dopaminergic imaging with ¹²³I-FP-CIT (DaTSCAN) in dementia with Lewy bodies (DLB).
METHODS: We included (a) studies in which DaTSCAN was performed in cases of diagnostic uncertainty to differentiate between DLB and non-DLB dementia and (b) studies of patients with already established diagnoses of DLB, non-DLB dementia, or normalcy, against which the diagnostic accuracy of DaTSCAN was tested. We applied fixed-effects Mantel-Haenszel and hierarchical logistic regression models for meta-analysis of the diagnostic test's accuracy. The pooled sensitivity, specificity and diagnostic odds ratio (DOR) were estimated. Heterogeneity among studies was estimated by calculating the corresponding I² statistic. We tested for publication or other bias by creating the respective funnel plot.
RESULTS: Four studies, with a total of 419 subjects, were judged to be suitable for meta-analysis. According to hierarchical models, the estimated pooled sensitivity of DaTSCAN in differentiating DLB versus no DLB was 86.5% [95% Confidence Intervals (CI): 72-94.1%], the specificity was 93.6% (95% CI: 88.5-96.6%), and the DOR was 94.2 (95% CI: 25.7-345). The Mantel-Haenszel estimate of overall DOR was calculated at 48.95 (95% CI: 26.16-91.59). There was some heterogeneity among studies (I² = 45%), but this was not found statistically significant (χ² test for heterogeneity p value = 0.142). Funnel plot analysis showed no significant bias.
CONCLUSION: Allowing for the small number of studies in the meta-analysis, our results showed high diagnostic accuracy of DaTSCAN in DLB diagnosis, especially in terms of specificity.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21975260     DOI: 10.1016/j.parkreldis.2011.09.015

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  24 in total

1.  Comment on: Dopamine Transporter (DaT) Scan Utilization in a Movement Disorder Center.

Authors:  Shakya Bhattacharjee; Vijaya Shankar; Mohammed Elkider
Journal:  Mov Disord Clin Pract       Date:  2016-05-09

Review 2.  Neuroimaging in Dementia.

Authors:  Adam M Staffaroni; Fanny M Elahi; Dana McDermott; Kacey Marton; Elissaios Karageorgiou; Simone Sacco; Matteo Paoletti; Eduardo Caverzasi; Christopher P Hess; Howard J Rosen; Michael D Geschwind
Journal:  Semin Neurol       Date:  2017-12-05       Impact factor: 3.420

3.  123I-FP-CIT SPECT findings and its clinical relevance in prodromal dementia with Lewy bodies.

Authors:  Koji Kasanuki; Eizo Iseki; Kazumi Ota; Daizo Kondo; Yosuke Ichimiya; Kiyoshi Sato; Heii Arai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-08-01       Impact factor: 9.236

Review 4.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

Review 5.  Multimodality imaging of Alzheimer disease and other neurodegenerative dementias.

Authors:  Ilya M Nasrallah; David A Wolk
Journal:  J Nucl Med       Date:  2014-11-20       Impact factor: 10.057

6.  Translating state-of-the-art brain magnetic resonance imaging (MRI) techniques into clinical practice: multimodal MRI differentiates dementia subtypes in a traditional clinical setting.

Authors:  Taylor Kuhn; Sergio Becerra; John Duncan; Norman Spivak; Bianca Huan Dang; Barshen Habelhah; Kennedy D Mahdavi; Michael Mamoun; Michael Whitney; F Scott Pereles; Alexander Bystritsky; Sheldon E Jordan
Journal:  Quant Imaging Med Surg       Date:  2021-09

7.  Imaging Dopaminergic Neurotransmission in Neurodegenerative Disorders.

Authors:  Elon D Wallert; Elsmarieke van de Giessen; Remco J J Knol; Martijn Beudel; Rob M A de Bie; Jan Booij
Journal:  J Nucl Med       Date:  2022-06       Impact factor: 11.082

Review 8.  Lewy body dementias.

Authors:  Zuzana Walker; Katherine L Possin; Bradley F Boeve; Dag Aarsland
Journal:  Lancet       Date:  2015-10-24       Impact factor: 79.321

9.  (123I)FP-CIT SPECT in suspected dementia with Lewy bodies: a longitudinal case study.

Authors:  Françoise J Siepel; Arvid Rongve; Tirza C Buter; Mona K Beyer; Clive G Ballard; Jan Booij; Dag Aarsland
Journal:  BMJ Open       Date:  2013-04-08       Impact factor: 2.692

10.  Can we clinically diagnose dementia with Lewy bodies yet?

Authors:  Yue Huang; Glenda Halliday
Journal:  Transl Neurodegener       Date:  2013-02-11       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.